Lasofoxifene Helps Reduce Risk Of Bone Fractures, Breast Cancer, Heart Disease And Stroke
Low doses of the medication lasofoxifene can reduce the risk of vertebral and non-vertebral fractures, ER-positive breast cancer, coronary heart disease and stroke in postmenopausal women with osteoporosis. That’s the finding of a new study in the latest issue of the New England Journal of Medicine…
Filed Under:
GeneralTagged:
Bone Cancer,
Bone Fractures,
Breast Cancer,
Breast Disease,
Breast Stroke,
Cancer Disease,
Coronary Heart Disease,
England Journal Of Medicine,
Heart Disease,
Heart Stroke,
Journal Of Medicine,
Lasofoxifene,
Medication,
New England,
New England Journal,
New England Journal Of Medicine,
New Medicine,
Osteoporosis,
Postmenopausal Women,
Vertebral Fractures,
Womens Health
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!